Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.200
-0.085-1.61%
Volume:879.00K
Turnover:4.50M
Market Cap:4.24B
PE:-22.31
High:5.340
Open:5.340
Low:5.000
Close:5.285
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:3.40
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:0.99
PE(LYR):-22.31
PS:4.52

Loading ...

Sun Pharma to Acquire Organon in $14 Per Share All-Cash Deal Valuing Company at $11.75 Billion

Deep News
·
Apr 27

ASCLETIS-B Shares Surge Over 4% in Morning Session as Key Pipeline Drug ASC30 Nears Phase III Trial

Stock News
·
Apr 24

Roche CEO Comments on Strong Swiss Franc, Boosts US Investment

Deep News
·
Apr 23

AbbVie Commits $1.4 Billion to Establish New Pharmaceutical Campus in North Carolina

Deep News
·
Apr 23

Pharma's "SpaceX" Sets Sail: The First AI-Driven Drug Delivery Pioneer, Jitai Tech Ushers in the Era of Biologics Delivery

Stock News
·
Apr 20

Insilico Medicine Surges Over 6% on AI-Driven Drug Discovery Advancements and Strategic Partnership

Stock News
·
Apr 20

ASCLETIS-B Nears Previous Peak, But Why Are Investors Staying on the Sidelines?

Stock News
·
Apr 18

ASCLETIS-B Shares Surge Nearly 5% in Afternoon Trading, Approaching All-Time High as GLP-1 and Amylin Combo Enters Clinical Trials

Stock News
·
Apr 17

CXO Concept Stocks Lead Declines in Hong Kong Market as Overseas Investment Environment Enters Volatile Phase

Stock News
·
Apr 17

Appeal Hearing Concludes for Hainan Poly Pharm Investor Compensation Case, Beijing Tongtech Claim Filed Again

Deep News
·
Apr 17

Hetero Pharma Aims for Global Sales Target of 1.5 Million Semaglutide Pens Annually

Deep News
·
Apr 16

Foreign Enterprise in Shanghai Donates 190 Boxes of Supplies to Support Seniors and Children

Deep News
·
Apr 16

AI-Powered Drug Development Enters Rapid Growth Phase, Transitioning from Proof-of-Concept to Commercialization

Stock News
·
Apr 13

Ocumension Therapeutics Reports No Share Capital Changes for March 2026; Option Activity Limited

Bulletin Express
·
Apr 08

Key Information Missing from Hanfang Pharmaceutical's Hong Kong IPO Prospectus

Deep News
·
Apr 08

ASCLETIS-B Advances Clinical Development of Fixed-Dose Combination ASC30_39 for Obesity Treatment

Stock News
·
Apr 07

Shanghai Stock Exchange Approves Tainuo Maibo's IPO Application

Deep News
·
Apr 03

Chemical Pharmaceutical Sector Performance Overview: Divergence Between Formulations and APIs, Innovative Drugmakers Stand Out

Deep News
·
Apr 03

Pharmaceutical Sector Defies Market Downturn with Strong Resilience

Deep News
·
Apr 02

Stock Track | OCUMENSION-B Soars 5.10% Intraday on Positive Analyst Rating

Stock Track
·
Apr 02